Resources
What Does an MRO Do in DOT Drug Testing?
The Medical Review Officer is the licensed physician who verifies certain DOT drug test results before your program receives a final report you can act on.
After a DOT specimen is collected and tested at the laboratory, a Medical Review Officer (MRO) may review the result before your designated employer representative or third-party administrator receives a verified final outcome.
That step exists to protect the integrity of the process, apply DOT review standards, and give employers a result they can actually use—not a preliminary lab notice that still needs medical review.
Short answer
A Medical Review Officer, or MRO, is the licensed physician who reviews certain DOT drug test results before the employer receives a verified final result. The MRO is there to protect the integrity of the process, apply DOT review standards, and give the employer a result it can actually act on.
Collectors complete the collection and chain-of-custody paperwork. They are not the MRO and do not issue the verified result your DER or TPA should rely on for program decisions.
Where the MRO fits in the DOT process
A simple employer view of the process looks like this: the specimen is collected; the lab tests the specimen; if the result requires review, the MRO evaluates it; the MRO verifies the final result; and the verified result is reported through the employer's designated path.
That means the collector and the MRO do different jobs. The collector handles the specimen and custody paperwork. The MRO handles medical review and final verification under DOT drug testing rules.
Employers should treat the verified result—not an early lab screen or hallway rumor—as the outcome that drives next steps. Your TPA or consortium defines the reporting path; the MRO sits between the lab and that verified report.
What the MRO actually does
The MRO may review non-negative or invalid laboratory findings, contact the donor confidentially, evaluate whether there is a legitimate medical explanation, verify the final result under DOT rules, and report the verified outcome to the TPA or DER workflow.
The MRO is not there to make an employment decision for the company. That decision stays with the employer and its program rules. Supervisors and HR should not ask collectors to interpret prescriptions or substitute their judgment for the MRO review step.
What employers should not do
Employers create avoidable risk when they treat a preliminary lab notice as a final result, ask a collector to interpret prescriptions, discuss an unverified result too broadly, or take discipline steps before the verified result is returned.
The safest practice is to wait for the verified result through the official reporting path. Premature conversations about a failed test create compliance and morale problems even when the MRO later verifies negative.
Keep the donor available for a confidential MRO call when requested. Blocking or delaying that contact can extend the case and leave supervisors acting on incomplete information.
Why this matters for DERs and supervisors
Supervisors and DERs do not need to know the medical details of every case, but they do need to understand that the MRO review step exists for a reason. It prevents the employer from acting on incomplete information and helps standardize the final result that drives program decisions.
Train front-line leaders on what they may say before verification—usually nothing beyond keeping the employee available and following your reasonable-suspicion or post-accident documentation rules. Medical details stay inside the DOT framework.
What happens after an MRO-verified result
That depends on the result and the program context. For some outcomes, the next step may involve removal from safety-sensitive duty, employer documentation, SAP referral, return-to-duty planning, or other actions managed by the DER and TPA.
See our SAP referral and return-to-duty guide for how employers typically move from a verified non-negative outcome into evaluation and follow-up testing. Coverage questions—who was in scope for DOT testing in the first place—are covered in who is covered by DOT drug testing.
Common employer questions
Does the collector tell us if the test is positive?
No. The collector does not issue the final verified result. The collector's job ends with a qualified collection, identity verification, and proper chain-of-custody paperwork. Final verification belongs to the MRO and the reporting path your TPA manages.
Does every DOT test go through an MRO review?
Every DOT drug-testing program uses MRO oversight, but employer attention usually focuses on the review when a result is not a straightforward negative. Negative results still flow through the program's reporting structure; non-negative and invalid outcomes trigger the review steps employers hear about most often.
Can we speak directly with the MRO?
That depends on your program structure and reporting path, but medical discussions are handled within the proper DOT framework. Employers typically work through the DER, TPA, or consortium rather than bypassing the process. Your administrator can explain who receives verified results and on what timeline.
Put the logistics on our side
Share program type, locations, and timelines—we respond with coverage and scheduling options suited to employer operations.